Experience with vincristine, doxorubicin, and dexamethasone (VAD) chemotherapy in adults with refractory acute lymphocytic leukemia.

Abstract:

:Sixty-four adult patients with refractory acute lymphocytic leukemia (ALL) received salvage therapy with the vincristine, doxorubicin (Adriamycin, Adria Laboratories, Columbus, OH), and dexamethasone (VAD) regimen consisting of induction chemotherapy with the three agents followed by multiple-agent maintenance therapy for 2 years. Overall, 25 patients (39%) achieved complete remission. The median remission duration was 28 weeks with 20% of these patients remaining disease-free at 2 years. The median overall survival was 23 weeks. Prognostic factors associated with differences in remission rates included patient performance status, hemoglobin and platelet levels, and degree of peripheral and marrow blastosis. Factors related to differences in survival were patient age and performance status, hemoglobin and platelet levels, percentage of peripheral blasts, and albumin and bilirubin levels. The toxicity of the regimen was minimal, with 33% of patients requiring hospitalization because of febrile episodes of unknown origin (17%) or documented infections (16%). Therapy-related mortality occurred in four patients (6%). We conclude that the VAD program has significant antileukemic efficacy and acceptable toxicity in adult salvage ALL.

journal_name

Cancer

journal_title

Cancer

authors

Kantarjian HM,Walters RS,Keating MJ,Barlogie B,McCredie KB,Freireich EJ

doi

10.1002/1097-0142(19890701)64:1<16::aid-cncr282064

subject

Has Abstract

pub_date

1989-07-01 00:00:00

pages

16-22

issue

1

eissn

0008-543X

issn

1097-0142

journal_volume

64

pub_type

杂志文章

相关文献

CANCER文献大全
  • Endodermal sinus tumor of the mediastinum.

    abstract::Endodermal sinus tumor (EST) of the mediastinum is a rare germ-cell neoplasm affecting mainly young adult males. Ten patients with EST were treated with a multimodality approach that included surgery, chemotherapy, and radiotherapy. All patients had relapses after achieving a transient response except one who is still...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820815)50:4<766::aid-cncr28205

    authors: Kuzur ME,Cobleigh MA,Greco FA,Einhorn LH,Oldham RK

    更新日期:1982-08-15 00:00:00

  • HL-A in cancer family "N".

    abstract::Actual HL-A typing has been performed on 115 members of cancer family N, a large kindred (over 1000 members ascertained) showing the findings consistent with the cancer family syndrome. In the cancer-prone line (branches C and D) of the family, 20 of 21 members with cancer had one HL-A haplotype, HL-A2-HL-A12 (relativ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197510)36:4<1315::aid-cncr282036

    authors: Lynch HT,Thomas RJ,Terasaki PI,Ting A,Guirgis HA,Kaplan AR,Magee H,Lynch J,Kraft C,Chaperon E

    更新日期:1975-10-01 00:00:00

  • Rhabdomyosarcoma presenting as a parotid gland mass in pediatric patients: fine-needle aspiration biopsy findings.

    abstract:BACKGROUND:The head and neck region is one of the most common locations of rhabdomyosarcoma. Salivary gland involvement is usually secondary to advanced disease, and presentation as a primary salivary gland tumor is very rare. METHODS:Three cases of rhabdomyosarcoma presenting as parotid masses, in 2 boys (ages 3 and ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Salomão DR,Sigman JD,Greenebaum E,Cohen MB

    更新日期:1998-08-25 00:00:00

  • Immunologic enhancement of B16 melanoma growth.

    abstract::In certain experimental tumor models, tumor growth is less pronounced in immune deficient animals. Characteristically, tumors such as the murine B16 melanoma and Lewis lung carcinoma (3LL) are weakly antigenic. We proposed that with such tumors that are weakly antigenic, growth is enhanced by T-cell factors. Young mic...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880501)61:9<1792::aid-cncr2820

    authors: Ershler WB,Tuck D,Moore AL,Klopp RG,Kramer KE

    更新日期:1988-05-01 00:00:00

  • Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.

    abstract:BACKGROUND:Coagulopathies often are associated with malignant tumors. The pathogenesis of these complications in cancer is not clear. Host inflammatory (monocyte/macrophage) cell-mediated triggering of clotting activation has been suggested. METHODS:The objective of this study was to evaluate the role of neutrophil-de...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19931001)72:7<2134::aid-cncr2820

    authors: Gabazza E,Taguchi O,Yamakami T,Machishi M,Ibata H,Suzuki S

    更新日期:1993-10-01 00:00:00

  • A review of Canadian health care and cancer care systems.

    abstract::Canada is a westernized, market-economy nation with a publicly funded health care and cancer control system and has health indices reflective of a high-resource economy. Provision of health services is in accord with the Canada Health Act and is implemented through federal, provincial, and territorial relations wherei...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26053

    authors: Sutcliffe SB

    更新日期:2011-05-15 00:00:00

  • Application of radiobiologic principles to radiation therapy.

    abstract::Oxygen remains one of the most potent sensitizers of mammalian cells yet studied and, most important, it is maximumly sensitizing at physiologic concentrations. There is very good evidence that solid tumors of both experimental animals and man contain hypoxic and viable cells. In experimental animals hyperbaric oxygen...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(196810)22:4<809::aid-cncr2820220

    authors: Suit HD

    更新日期:1968-10-01 00:00:00

  • Getting key players to work together and defending against diversion--California.

    abstract::In 1988, Californians passed Proposition 99, which raised the tobacco tax from 10 cents to 35 cents and allocated 20% of the resulting revenues, approximately $100 million, for tobacco education and 5% for tobacco-related research. Seventy percent was allocated for health care costs and 5% for the environment. In this...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19981215)83:12a+<2697::aid

    authors: Martin CB,Beerline D,Breslow L

    更新日期:1998-12-15 00:00:00

  • Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials.

    abstract:BACKGROUND:Attrition is common among supportive care/palliative oncology clinical trials. However, to the authors' knowledge, few studies to date have documented the reasons and predictors for dropout. In the current study, the authors' objective was to determine the rate, reasons, and factors associated with attrition...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27854

    authors: Hui D,Glitza I,Chisholm G,Yennu S,Bruera E

    更新日期:2013-03-01 00:00:00

  • Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates.

    abstract::Data on patients with gallbladder cancer listed in the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute were reviewed. Between 1977 and 1986, 3038 patients were recorded in the Program. Histologic grade, histologic type, stage of disease, and vascular invasion were correlated...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920915)70:6<1493::aid-cncr2820

    authors: Henson DE,Albores-Saavedra J,Corle D

    更新日期:1992-09-15 00:00:00

  • SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.

    abstract:BACKGROUND:In preclinical Ewing sarcoma (ES) models, poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors were identified as a potential therapeutic strategy with synergy in combination with cytotoxic agents. This study evaluated the safety and dosing of the PARP1/2 inhibitor niraparib (NIR) with temozolomid...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33349

    authors: Chugh R,Ballman KV,Helman LJ,Patel S,Whelan JS,Widemann B,Lu Y,Hawkins DS,Mascarenhas L,Glod JW,Ji J,Zhang Y,Reinke D,Strauss SJ

    更新日期:2020-12-08 00:00:00

  • Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

    abstract:BACKGROUND:To the authors' knowledge, outcomes and prognostic tools have yet to be clearly defined in patients with metastatic renal cell carcinoma (mRCC) who are treated with immuno-oncology (IO) checkpoint inhibitors (programmed death-ligand 1 [PD-L1] inhibitors). In the current study, the authors aimed to establish ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.31595

    authors: Yip SM,Wells C,Moreira R,Wong A,Srinivas S,Beuselinck B,Porta C,Sim HW,Ernst DS,Rini BI,Yuasa T,Basappa NS,Kanesvaran R,Wood LA,Canil C,Kapoor A,Fu SYF,Choueiri TK,Heng DYC

    更新日期:2018-09-15 00:00:00

  • Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958-1984.

    abstract::Twenty-four children aged 3 months to 18 years (median, 12 years) were treated for neurogenic sarcoma at the Children's Hospital of Philadelphia Cancer Research Center from 1958 through 1984. Sixteen patients had neurofibromatosis (NF). The tumors arose in an extremity or in the trunk (15 patients), the retroperitoneu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870101)59:1<1::aid-cncr2820590

    authors: Raney B,Schnaufer L,Ziegler M,Chatten J,Littman P,Jarrett P

    更新日期:1987-01-01 00:00:00

  • Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.

    abstract:BACKGROUND:Male breast cancer (MBC) is considered an androgen-dependent tumor, and as in prostatic cancer, responses have been reported with use of antiandrogens or gonadotropin-releasing hormone analogs. Thus, it is reasonable to postulate that better results could be achieved by combining these two agents. METHODS:E...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930715)72:2<502::aid-cncr28207

    authors: Lopez M,Natali M,Di Lauro L,Vici P,Pignatti F,Carpano S

    更新日期:1993-07-15 00:00:00

  • Combined BCG and irradiation treatment of skin metastases originating from malignant melanoma.

    abstract::Treatment with BCG (Bacillus Calmette-Guérin) followed by irradiation was attempted to improve response to therapy by cutaneous metastases from malignant skin melanomas. Both agents were applied in low doses, known to cause minimal side effects. Nineteen patients, divided into three groups, entered the clinical trial....

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820915)50:6<1100::aid-cncr2820

    authors: Plesnicar S,Rudolf Z

    更新日期:1982-09-15 00:00:00

  • Ultrastructural characteristics of therapy-related acute nonlymphocytic leukemia: evidence for a panmyelosis.

    abstract::Leukemic cells from 13 patients with therapy-related acute nonlymphocytic leukemia (ANLL) were studied by electron microscopy. All of the patients had radiotherapy, and/or alkylating agent chemotherapy for other neoplastic disease 25 to 182 months prior to the diagnosis of ANLL. All cases manifested ultrastructural ev...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810801)48:3<725::aid-cncr28204

    authors: McKenna RW,Parkin JL,Foucar K,Brunning RD

    更新日期:1981-08-01 00:00:00

  • A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma.

    abstract::Based on the independent activity of cisplatin, vinblastine, and dimethyl-triazeno-imidazole-carboxamide (DTIC) (CVD), a combination of these agents was used in the treatment of patients with advanced melanoma. Vinblastine was used in a dose of 1.6 mg/m2/d for 5 days, DTIC was used in a dose of 800 mg/m2 intravenously...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19891115)64:10<2024::aid-cncr282

    authors: Legha SS,Ring S,Papadopoulos N,Plager C,Chawla S,Benjamin R

    更新日期:1989-11-15 00:00:00

  • Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.

    abstract:BACKGROUND:The incidence of hepatocellular carcinoma (HCC) has been rising rapidly in the United States. California is an ethnically diverse state with the largest number of incident HCC cases in the country. Characterizing HCC disparities in California may inform priorities for HCC prevention. METHODS:By using data f...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31598

    authors: Yang B,Liu JB,So SK,Han SS,Wang SS,Hertz A,Shariff-Marco S,Lin Gomez S,Rosenberg PS,Nguyen MH,Hsing AW

    更新日期:2018-09-01 00:00:00

  • Combination versus successive single agent chemotherapy in lymphocytic lymphoma.

    abstract::Fifty-three patients with advanced lymphocytic lymphoma were randomly assigned to treatment with the combination cyclophosphamide, vincristine, and prednisone (CVP) or the same agents used successively in maximal doses (C-V-P). Complete remissions occurred in 68% with CVP and 48% with C-V-P. For patients with nodular ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(197801)41:1<23::aid-cncr28204101

    authors: Kennedy BJ,Bloomfield CD,Kiang DT,Vosika G,Peterson BA,Theologides A

    更新日期:1978-01-01 00:00:00

  • A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas.

    abstract:BACKGROUND:Preclinical and clinical data suggest that both leucovorin (LV) and interferon (IFN) can augment the cytotoxic effects of 5-fluorouracil (5-FU). Based on the rationale of biochemical double modulation, the current Phase II study was undertaken. METHODS:Thirty-two previously untreated patients with advanced ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19921001)70:7<1864::aid-cncr2820

    authors: Scheithauer W,Pfeffel F,Kornek G,Marczell A,Wiltschke C,Funovics J

    更新日期:1992-10-01 00:00:00

  • Long-term outcomes of adult survivors of childhood cancer.

    abstract::During the past 30 years, changes in the treatment of children and adolescents with cancer have led to substantial improvements in survival. Although treatment-related factors have been shown to impact subsequent health status and quality of life, there is limited information on survivors who are now two or more decad...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.21249

    authors: Robison LL,Green DM,Hudson M,Meadows AT,Mertens AC,Packer RJ,Sklar CA,Strong LC,Yasui Y,Zeltzer LK

    更新日期:2005-12-01 00:00:00

  • Body composition in cachexia resulting from malignant and non-malignant diseases.

    abstract::The body composition of 23 patients with cachexia resulting from malignant or benign inflammatory disease was studied. Skinfold thickness and radioisotope tracer measurements enabled us to estimate total body fat, lean body mass, the ratio of fat loss to lean body loss, erythrocyte and plasma volumes, total body water...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801101)46:9<2041::aid-cncr2820

    authors: Watson WS,Sammon AM

    更新日期:1980-11-01 00:00:00

  • A study of 15 cases of primary mediastinal lymphoma of B-cell type.

    abstract::Fifteen cases of pure supradiapragmatic lymphoma with initial prominent antero-superior mediastinal involvement displaying a B-cell pattern of reactivity were studied. These cases occurred in six men and nine women with a median age of 33 years at diagnosis (range, 23 to 75 years). Supradiapragmatic peripheral lymphad...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920515)69:10<2561::aid-cncr282

    authors: Lavabre-Bertrand T,Donadio D,Fegueux N,Jessueld D,Taib J,Charlier D,Rousset T,Emberger JM,Baldet P,Navarro M

    更新日期:1992-05-15 00:00:00

  • Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States.

    abstract:BACKGROUND:Oral tongue cancer incidence has increased among whites in the United States; however, the cause remains unknown. If an infectious agent is implicated, then elevated risk would be expected among immunosuppressed individuals. METHODS:By using population-based registry linkage information from the US Transpla...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31359

    authors: Tota JE,Engels EA,Madeleine MM,Clarke CA,Lynch CF,Ortiz AP,Hernandez BY,Chaturvedi AK

    更新日期:2018-06-15 00:00:00

  • Does multisomy of chromosome 1q confer a proliferative advantage in B-cell acute lymphoblastic leukemia?

    abstract::Two patients fulfilled the clinical and hematologic criteria for B-cell acute lymphoblastic leukemia: the malignant cells had L3 morphology, bore B-cell markers, and carried the specific t(8;14) translocation. The leukemic cells of one patient were tetrasomic for 1q, and those of the other patient showed several separ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840701)54:1<48::aid-cncr282054

    authors: Morris CM,Fitzgerald PH,Neville MA,Wyld PJ,Beard ME

    更新日期:1984-07-01 00:00:00

  • Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer.

    abstract::A retrospective analysis of a series of 162 patients treated for isolated chest wall recurrence of breast cancer after mastectomy was undertaken. Cumulative survival, distant relapse-free survival, and freedom from local progression after 5 years from the diagnosis of recurrence were 34%, 28%, and 45% respectively. Fi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870715)60:2<240::aid-cncr28206

    authors: Magno L,Bignardi M,Micheletti E,Bardelli D,Plebani F

    更新日期:1987-07-15 00:00:00

  • Gemcitabine and platinum combinations in pancreatic cancer.

    abstract::Progress in the treatment of pancreatic cancer in the past several decades has been very modest. Several new agents with activity against this disease have been identified. Of these, gemcitabine appears to be the most promising when used in combination with other drugs. Gemcitabine and cisplatin combinations have been...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.10757

    authors: Philip PA

    更新日期:2002-08-15 00:00:00

  • Polyamines in malignant melanoma. Urinary excretion and disease progress.

    abstract::Urinary polyamine concentrations in 91 samples were assayed in 79 patients with malignant melanoma who were classified as to clinical stage, as well as to activity of disease. Patients with active disease had higher mean polyamine values, increased frequency of polyamine elevations, and increased frequency of two or m...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197611)38:5<2088::aid-cncr282038

    authors: Townsend RM,Banda PW,Marton LJ

    更新日期:1976-11-01 00:00:00

  • Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials.

    abstract:BACKGROUND:The authors investigated the putative surrogate endpoints of best response, complete response (CR), confirmed response, and progression-free survival (PFS) for associations with overall survival (OS), and as possible surrogate endpoints for OS. METHODS:Individual patient data from 870 untreated extensive st...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.25526

    authors: Foster NR,Qi Y,Shi Q,Krook JE,Kugler JW,Jett JR,Molina JR,Schild SE,Adjei AA,Mandrekar SJ

    更新日期:2011-03-15 00:00:00

  • A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine.

    abstract::This article describes two patients with hepatic metastases from colorectal cancer in whom a reversible enteropathy developed during the administration of hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine (5-FUdR) via an Infusaid Series 400 pump (Infusaid Corp., Sharon, MA). Both patients had severe di...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19851115)56:10<2424::aid-cncr282

    authors: Gluck WL,Akwari OE,Kelvin FM,Goodwin BJ

    更新日期:1985-11-15 00:00:00